Illumina Says Icahn Nominees Would 'Damage' Core Business
Life sciences company Illumina on Monday dismissed Carl Icahn's efforts to install his hand-picked nominees to the company's board, claiming they would do nothing to "accelerate the legal and regulatory processes"...To view the full article, register now.
Already a subscriber? Click here to view full article